Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-31 Option Award |
2025-04-02 09:03 am |
N/A 2035-03-31 |
Pyxis Oncology Inc. | PYXS | HUMPHREY RACHEL Director |
36,979 | $0.98 | 36,979 (Direct) |
View |
| 2024-03-26 Option Award |
2024-03-28 4:32 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | HUMPHREY RACHEL Director |
38,741 | $0 | 96,805 (Direct) |
View |
| 2023-03-24 Option Award |
2023-03-28 4:43 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | HUMPHREY RACHEL Director |
58,064 | $0 | 58,064 (Direct) |
View |
| 2022-08-11 Option Award |
2022-08-15 5:44 pm |
N/A 2032-08-11 |
Pyxis Oncology Inc. | PYXS | HUMPHREY RACHEL Director |
236,220 | $0 | 236,220 (Direct) |
View |
Ownership |
2021-10-21 8:41 pm |
N/A N/A |
Xilio Therapeutics Inc. | XLO | HUMPHREY RACHEL Director |
0 | $0 | 58,133 (Direct) |
View |
| 2021-02-17 Option Award |
2021-02-19 6:55 pm |
N/A 2031-02-16 |
Black Diamond Therapeutics Inc. | BDTX | HUMPHREY RACHEL Chief Medical Officer |
60,000 | $0 | 60,000 (Direct) |
View |
| 2020-09-08 Option Award |
2020-09-10 4:56 pm |
N/A 2030-09-08 |
Black Diamond Therapeutics Inc. | BDTX | HUMPHREY RACHEL Chief Medical Officer |
160,000 | $0 | 160,000 (Direct) |
View |